Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 6
2020 9
2021 4
2022 3
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types.
Willumsen N, Jensen C, Green G, Nissen NI, Neely J, Nelson DM, Pedersen RS, Frederiksen P, Chen IM, Boisen MK, Johansen AZ, Madsen DH, Svane IM, Lipton A, Leitzel K, Ali SM, Erler JT, Hurkmans DP, Mathijssen RHJ, Aerts J, Eslam M, George J, Christiansen C, Bissel MJ, Karsdal MA. Willumsen N, et al. Among authors: hurkmans dp. Cell Mol Life Sci. 2022 Mar 25;79(4):204. doi: 10.1007/s00018-022-04226-0. Cell Mol Life Sci. 2022. PMID: 35332383 Free PMC article. Review.
Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen.
Hussaarts KGAM, Hurkmans DP, Oomen-de Hoop E, van Harten LJ, Berghuis S, van Alphen RJ, Spierings LEA, van Rossum-Schornagel QC, Vastbinder MB, van Schaik RHN, van Gelder T, Jager A, van Leeuwen RWF, Mathijssen RHJ. Hussaarts KGAM, et al. Among authors: hurkmans dp. Cancers (Basel). 2019 Mar 22;11(3):403. doi: 10.3390/cancers11030403. Cancers (Basel). 2019. PMID: 30909366 Free PMC article.
Correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancer.
Basak EA, Koolen SLW, Hurkmans DP, Schreurs MWJ, Bins S, Oomen-de Hoop E, Wijkhuijs AJM, Besten ID, Sleijfer S, Debets R, van der Veldt AAM, Aerts JGJV, Mathijssen RHJ. Basak EA, et al. Among authors: hurkmans dp. Eur J Cancer. 2019 Mar;109:12-20. doi: 10.1016/j.ejca.2018.12.008. Epub 2019 Jan 14. Eur J Cancer. 2019. PMID: 30654225
Associations between patient and disease characteristics and severe adverse events during immune checkpoint inhibitor treatment: An observational study.
Basak EA, Vermeer NS, de Joode K, Hurkmans DP, Velthuis DEM, Oomen-de Hoop E, Schreurs MWJ, Bins S, Koolen SLW, Debets R, van der Veldt AAM, Aerts JGJV, Joosse A, Mathijssen RHJ. Basak EA, et al. Among authors: hurkmans dp. Eur J Cancer. 2022 Oct;174:113-120. doi: 10.1016/j.ejca.2022.07.015. Epub 2022 Aug 19. Eur J Cancer. 2022. PMID: 35988409 Free article.
Influence of esomeprazole on the bioavailability of afatinib: A pharmacokinetic cross-over study in patients with non-small cell lung cancer.
Veerman GDM, Hurkmans DP, Paats MS, Oomen-de Hoop E, van der Leest CH, van Thiel ERE, Aerts JGJV, van Leeuwen RW, Dingemans AC, Mathijssen RHJ. Veerman GDM, et al. Among authors: hurkmans dp. Biomed Pharmacother. 2022 Nov;155:113695. doi: 10.1016/j.biopha.2022.113695. Epub 2022 Sep 19. Biomed Pharmacother. 2022. PMID: 36126454 Free article. Clinical Trial.
21 results